ARTIFICIAL ORGANS is a leading academic journal published by Wiley, focusing on the interdisciplinary fields of bioengineering, biomaterials, and biomedical engineering. Established in 1977 and continuing through 2024, this journal plays a pivotal role in advancing research related to artificial organs and their impact on healthcare innovations. With an impressive impact factor and notable Q2 rankings across multiple categories, including Medicine and Biomedical Engineering, ARTIFICIAL ORGANS caters to a global audience of researchers, professionals, and students devoted to the latest developments in organ replacement and regenerative medicine. Although not an open-access journal, it maintains a rich repository of essential research articles, reviews, and case studies that collectively enhance the scientific community's understanding of artificial organ technologies. By publishing high-quality, peer-reviewed content, ARTIFICIAL ORGANS remains a vital source for emerging knowledge and collaborations in the exciting field of artificial organ research.

BIOTECHNOLOGY AND BIOENGINEERING, published by Wiley, is a leading journal in the domains of applied microbiology, biotechnology, and bioengineering. With an ISSN of 0006-3592 and E-ISSN of 1097-0290, this journal has established itself as an essential resource for researchers, professionals, and students aiming to advance their knowledge and stay updated on cutting-edge innovations and methodologies in biotechnology. The journal has a commendable impact factor, and it is ranked in the second quartile (Q2) across multiple categories for 2023. This positions it favorably among its peers, underscoring its significance in the scientific community; for example, it ranks 23rd out of 127 in the field of Applied Microbiology and Biotechnology. As a hub of critical research findings and technological advancements, BIOTECHNOLOGY AND BIOENGINEERING invites contributions that push the boundaries of biotechnological applications, fostering a deeper understanding and development of sustainable solutions to current global challenges.

Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.

Journal of the Mechanical Behavior of Biomedical Materials is a leading academic publication dedicated to the intersection of mechanical engineering and biomedical innovation. Published by ELSEVIER in the Netherlands, this journal, which holds a solid presence within Q2 in Biomaterials and Biomedical Engineering, and Q1 in Mechanics of Materials as of 2023, features high-impact research with a measurable Scopus ranking that places it in the top tier of its fields. With an impressive percentile performance—82nd in Mechanics of Materials and 73rd in Biomedical Engineering—this journal serves as a vital resource for researchers, students, and professionals seeking to enrich their understanding of the mechanical behaviors of biomaterials and their applications. Spanning converged years from 2008 to 2024, it provides access to a wealth of pioneering research that advances the knowledge essential for the development of innovative biomedical applications. Engage with cutting-edge studies and broaden your expertise in the rapidly evolving realms of biomaterials and biomedical engineering through this authoritative publication.

Tissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.

CELL TRANSPLANTATION is a premier multidisciplinary journal dedicated to advancing the field of regenerative medicine and transplantation, published by SAGE PUBLICATIONS INC. Since its initiation in 1992 and embracing an open-access model since 2017, the journal aims to disseminate high-quality research that covers both clinical and experimental studies on cell and tissue transplantation. With a notable impact reflected in its 2023 Q2 ranking in Biomedical Engineering and significant standings in Cell Biology and Transplantation, CELL TRANSPLANTATION serves as a vital resource for researchers, practitioners, and students alike. The journal's commitment to fostering innovation is evident in its diverse contributions that address the complexities of tissue engineering, immunology, and regenerative therapies, inviting readers to engage with cutting-edge science that is poised to transform medical practices and improve patient outcomes. The journal's insightful articles and research findings make it a crucial platform for knowledge exchange within the vibrant scientific community.

MACROMOLECULAR BIOSCIENCE, published by WILEY-V C H VERLAG GMBH, is a leading journal in the fields of bioengineering, biomaterials, biotechnology, materials chemistry, and polymers and plastics. With a convergence of scientific inquiry since its inception in 2001, the journal has established itself as a vital resource for researchers and professionals exploring the interface of molecular sciences and biosystems. It boasts impressive Scopus rankings, including Q1 status in multiple categories, reflecting its significant contribution to advancing knowledge and innovation in the polymer and biomaterials domains. While the journal does not currently offer open access options, its rigorous peer-review process ensures the publication of high-quality research that fuels academic discourse. Positioned in Weinheim, Germany, MACROMOLECULAR BIOSCIENCE aims to bridge theoretical understanding with practical applications, making it an essential reference for students, academics, and industry practitioners dedicated to the evolving landscape of macromolecular bioscience.

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

BIOMATERIALS, published by Elsevier Science Ltd, is a premier academic journal dedicated to the interdisciplinary field of biomaterials research. With an impressive impact factor, it ranks in the Q1 quartile across multiple categories including Bioengineering, Biomaterials, and Biophysics, showcasing its significance in advancing scientific knowledge. Established in 1980 and set to converge its discussions through 2025, this journal provides a critical platform for researchers and professionals to disseminate their findings on the development, application, and performance of biomaterials. The journal covers a wide range of topics, from the mechanics of materials to nanotechnology, and is highly regarded with top Scopus rankings in essential categories, including an exceptional position within the 99th percentile for Biophysics. Although not an open access journal, BIOMATERIALS remains vital for students and established researchers alike, ensuring accessibility to groundbreaking research in the field. Engage with cutting-edge studies that pave the way for innovative applications in medicine, engineering, and beyond.

Biomedical Physics & Engineering Express, published by IOP Publishing Ltd, serves as a dynamic platform for the dissemination of groundbreaking research in the interdisciplinary domains of biomedical physics, engineering, and related fields. With a focus on innovative solutions for healthcare challenges, the journal extends its reach to a global audience, providing valuable insights that influence both academic research and practical applications. Operating under an open-access format, this journal ensures that vital scientific discoveries are readily available to researchers, professionals, and students alike. Ranking within the Q3 and Q4 quartiles across various categories—including Bioengineering and Biomedical Engineering—indicates its emerging influence in the scientific community since its inception in 2015. With an increasing footprint in Scopus rankings and a commitment to advancing knowledge in subfields such as biophysics and health informatics, Biomedical Physics & Engineering Express plays a crucial role in shaping future innovations in healthcare technology and patient care.